We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
3 Healthcare Mutual Funds You Should Consider Buying
Read MoreHide Full Article
One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services does not change with market conditions. Many pharmaceutical companies also pay out regular dividends.
Companies that consistently offer dividends are financially stable and generate a steady cash flow, irrespective of market conditions. Mutual funds are the perfect choice for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Fidelity Select Pharmaceuticals Portfolio fund invests most of its net assets in common stocks of foreign and domestic companies that are engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. FPHAX advisors choose to invest in stocks based on fundamental analysis factors like the issuer's financial condition, industry position, as well as market and economic condition.
Fidelity Select Pharmaceuticals Portfolio fund has five-year annualized returns of 14.4%. As of the end of February 2024, FPHAX held 60 issues, with 24.2% of its assets invested in Eli Lilly & Co.
Fidelity Select Medical Technology and Devices Portfolio fund invests most of its net assets in common stocks of foreign and domestic companies that are principally engaged in the research, development, manufacture, distribution, supply, or sale of medical equipment, devices, and related technologies, companies enabling drug discovery. FSMEX advisors also invest in companies providing information technology services primarily to healthcare providers.
Fidelity Select Medical Technology and Devices Portfolio fund has five-year annualized returns of 8.3%. FSMEX has an expense ratio of 0.70%.
Fidelity Select Biotechnology fund invests most of its net assets in common stocks of foreign and domestic companies that are principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. FBIOX advisors choose to invest in stocks based on fundamental analysis factors like the issuer's financial condition, industry position, as well as market and economic condition.
Fidelity Select Biotechnology fund has five-year annualized returns of 5.6%. Rajiv Kaul has been the fund manager of FBIOX since October 2005.
Image: Shutterstock
3 Healthcare Mutual Funds You Should Consider Buying
One of the best ways to safeguard investments is by parking money in the healthcare sector. This is because demand for healthcare services does not change with market conditions. Many pharmaceutical companies also pay out regular dividends.
Companies that consistently offer dividends are financially stable and generate a steady cash flow, irrespective of market conditions. Mutual funds are the perfect choice for investors looking to enter this sector since they possess the advantages of wide diversification and analytical insight.
Below, we share with you three healthcare mutual funds, namely Fidelity Select Pharmaceuticals Portfolio (FPHAX - Free Report) , Fidelity Select Medical Technology and Devices Portfolio (FSMEX - Free Report) and Fidelity Select Biotechnology (FBIOX - Free Report) . Each has earned a Zacks Mutual Fund Rank #1 (Strong Buy) and is expected to outperform its peers in the future. Investors can click here to see the complete list of funds.
Fidelity Select Pharmaceuticals Portfolio fund invests most of its net assets in common stocks of foreign and domestic companies that are engaged in the research, development, manufacture, sale, or distribution of pharmaceuticals and drugs of all types. FPHAX advisors choose to invest in stocks based on fundamental analysis factors like the issuer's financial condition, industry position, as well as market and economic condition.
Fidelity Select Pharmaceuticals Portfolio fund has five-year annualized returns of 14.4%. As of the end of February 2024, FPHAX held 60 issues, with 24.2% of its assets invested in Eli Lilly & Co.
Fidelity Select Medical Technology and Devices Portfolio fund invests most of its net assets in common stocks of foreign and domestic companies that are principally engaged in the research, development, manufacture, distribution, supply, or sale of medical equipment, devices, and related technologies, companies enabling drug discovery. FSMEX advisors also invest in companies providing information technology services primarily to healthcare providers.
Fidelity Select Medical Technology and Devices Portfolio fund has five-year annualized returns of 8.3%. FSMEX has an expense ratio of 0.70%.
Fidelity Select Biotechnology fund invests most of its net assets in common stocks of foreign and domestic companies that are principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. FBIOX advisors choose to invest in stocks based on fundamental analysis factors like the issuer's financial condition, industry position, as well as market and economic condition.
Fidelity Select Biotechnology fund has five-year annualized returns of 5.6%. Rajiv Kaul has been the fund manager of FBIOX since October 2005.
To view the Zacks Rank and the past performance of all Healthcare mutual funds, investors can click here to see the complete list of healthcare mutual funds.
Want key mutual fund info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing mutual funds, each week. Get it free >>